J. Kraus

发表

Virtual high-throughput screening of molecular databases.

Markus H. J. Seifert, J. Kraus, B. Kramer, 2007, Current opinion in drug discovery & development.

Loss of locomotor sensitisation in response to morphine in D1 receptor deficient mice

H. Schroeder, S. Schulz, B. Peters, 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

HPLC−CD On-Line Coupling in Combination with HPLC−NMR and HPLC−MS/MS for the Determination of the Full Absolute Stereostructure of New Metabolites in Plant Extracts

Gerhard Bringmann, M. Wohlfarth, G. Bringmann, 1999 .

Distinct palindromic extensions of the 5’‐TTC…GAA‐3’ motif allow STAT6 binding in vivo

J. Kraus, V. Höllt, Christine Börner, 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Small-sized low-density lipoproteins of subclass B from patients with end-stage renal disease effectively augment tumor necrosis factor-alpha-induced adhesive properties in human endothelial cells.

J. Kraus, J. Dierkes, Regina Müller, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Contrasting Effects of Long-Term Treatment with IFN-γ in Endothelial Cells: Increase in IL-6 Secretion Versus Decrease in IL-8 Secretion, NF-κB, and AP-1 Activation

W. König, J. Kraus, S. Borgmann, 2002 .

Regulation of mouse somatostatin receptor type 2 gene expression by glucocorticoids

J. Kraus, M. Wöltje, V. Höllt, 1999, FEBS letters.

Alternative promoter usage and tissue specific expression of the mouse somatostatin receptor 2 gene

J. Kraus, M. Wöltje, V. Höllt, 1998, FEBS letters.

Gene structure and regulation of the somatostatin receptor type 2

J. Kraus, M. Wöltje, V. Höllt, 2000, Journal of Physiology-Paris.

Identification of a functional 3′,5′‐cyclic adenosine monophosphate response element within the second promoter of the mouse somatostatin receptor type 2 gene

J. Kraus, M. Wöltje, V. Höllt, 1998, FEBS letters.

MicroRNA let-7d is a target of cannabinoid CB1 receptor and controls cannabinoid signaling

I. Galve-Roperh, M. Guzmán, C. Blázquez, 2016, Neuropharmacology.

Regulatory elements of the human proopiomelanocortin gene promoter.

M. Buchfelder, J. Kraus, V. Höllt, 1993, DNA and cell biology.

μ‐Opioid receptor‐stimulated synthesis of reactive oxygen species is mediated via phospholipase D2

J. Kraus, L. Brandenburg, V. Höllt, 2009, Journal of neurochemistry.

4-Oxonicotinamide-1-(1′-β-d-ribofuranoside) from Rothmannia longiflora Salisb. (Rubiaceae)

M. Herderich, G. Bringmann, K. Peters, 1999 .

Contrasting effects of long-term treatment with IFN-gamma in endothelial cells: increase in IL-6 secretion versus decrease in IL-8 secretion, NF-kappa B, and AP-1 activation.

W. König, J. Kraus, S. Borgmann, 2002, Endothelium : journal of endothelial cell research.

Cannabinoid Receptor Type 1- and 2-mediated Increase in Cyclic AMP Inhibits T Cell Receptor-triggered Signaling*

B. Schraven, M. Šmída, J. Kraus, 2009, The Journal of Biological Chemistry.

Mechanisms of the Inhibition of Nuclear Factor-κB by Morphine in Neuronal Cells

J. Kraus, V. Höllt, Christine Börner, 2012, Molecular Pharmacology.

Non-competitive inhibitors of metabotropic glutamate receptor 5 (mGluR5).

J. Kraus, E. Poggesi, A. Leonardi, 2005, Bioorganic & medicinal chemistry letters.

Short title: Cannabinoids Induce µ-Opioid Receptors in T Cells

J. Kraus, 2016 .

Analysis of Promoter Regions Regulating Basal and Interleukin-4-Inducible Expression of the Human CB1 Receptor Gene in T Lymphocytes

J. Kraus, A. Bedini, V. Höllt, 2008, Molecular Pharmacology.

Activation of Human T Cells Induces Upregulation of Cannabinoid Receptor Type 1 Transcription

J. Kraus, V. Höllt, Christine Börner, 2008, Neuroimmunomodulation.

Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids

W. Sebald, J. Kraus, V. Höllt, 2007, Journal of leukocyte biology.

Cannabinoid Receptor Type 2 Agonists Induce Transcription of the μ-Opioid Receptor Gene in Jurkat T Cells

J. Kraus, V. Höllt, Christine Börner, 2006, Molecular Pharmacology.

Inhibition of NF-κB by Opioids in T Cells

J. Kraus, Christine Börner, 2013, The Journal of Immunology.

Involvement of activator protein-1 in transcriptional regulation of the human mu-opioid receptor gene.

J. Kraus, V. Höllt, Christine Börner, 2002, Molecular pharmacology.

Promoter Region and Alternatively Spliced Exons of the Rat μ‐Opioid Receptor Gene

A. Zimprich, J. Kraus, S. Schulzeck, 1996, Journal of neurochemistry.

Molecular cloning and functional analysis of the rat mu opioid receptor gene promoter.

G. Horn, A. Zimprich, J. Kraus, 1995, Biochemical and biophysical research communications.

Mu opioid receptor agonist-selective regulation of interleukin-4 in T lymphocytes

J. Kraus, V. Höllt, T. Koch, 2013, Journal of Neuroimmunology.

Interferon-γ down-regulates transcription of the μ-opioid receptor gene in neuronal and immune cells

U. Lendeckel, J. Kraus, V. Höllt, 2006, Journal of Neuroimmunology.

Morphine self-administration in µ-opioid receptor-deficient mice

H. Schroeder, H. Loh, B. Peters, 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

Comparative analysis of mu-opioid receptor expression in immune and neuronal cells

J. Kraus, V. Höllt, R. Stumm, 2007, Journal of Neuroimmunology.

Mechanisms of Opioid-Mediated Inhibition of Human T Cell Receptor Signaling1

B. Schraven, R. Hartig, M. Šmída, 2009, The Journal of Immunology.

Jozimine B, a Constitutionally Unsymmetric, Antiplasmodial ‘Dimer’ of the Naphthylisoquinoline Alkaloid Ancistrocladine

G. Bringmann, R. Brun, J. Kraus, 2000 .

Nondynamic and Dynamic Kinetic Resolution of Lactones with Stereogenic Centers and Axes: Stereoselective Total Synthesis of Herbertenediol and Mastigophorenes A and B†

G. Bringmann, T. Pabst, K. Peters, 2000 .

Atropo‐Enantioselective Synthesis of the Natural Bicoumarin (+)‐Isokotanin A via a Configurationally Stable Biaryl Lactone

G. Bringmann, K. Peters, J. Kraus, 2002 .

Atropo-enantioselective total synthesis of knipholone and related antiplasmodial phenylanthraquinones.

G. Bringmann, K. Peters, R. Brun, 2002, The Journal of organic chemistry.

Determination of the Absolute Configurations of γ‐Rubromycin and Related Spiro Compounds by Quantum Chemical CD Calculations

G. Bringmann, A. Zeeck, C. Puder, 2000 .

Elucidation of the conformations and absolute configurations of enantiomerically pure tetralin derivatives

G. Bringmann, J. Kraus, G. Tóth, 1999 .

Elucidation of the absolute configuration of knipholone and knipholone anthrone by quantum chemical CD calculations

G. Bringmann, J. Kraus, D. Menche, 1999 .

Gardenamide A fromRothmannia urcelliformis (Rubiaceae) − Isolation, Absolute Stereostructure, and Biomimetic Synthesis from Genipine

G. Bringmann, M. Ochse, J. Kraus, 2001 .

Interaction of phloretin with membranes: on the mode of action of phloretin at the water-lipid interface

R. Benz, G. Bringmann, J. Kraus, 2000, European Biophysics Journal.

The ortho-hydroxy-ortho′-formyl biaryl/lactol equilibrium: Quantumchemical studies on structure and dynamics☆

G. Bringmann, J. Kraus, D. Vitt, 1998 .

Synthesis and structure of a novel twofold lactone-bridged ternaphthyl

K. Peters, J. Kraus, E. Peters, 1998 .

Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.

J. Lucas, G. Marsicano, B. Lutz, 2011, Brain : a journal of neurology.

Regulation of μ-Opioid Receptor Gene Transcription by Interleukin-4 and Influence of an Allelic Variation within a STAT6 Transcription Factor Binding Site*

J. Kraus, M. Hoehe, V. Höllt, 2001, The Journal of Biological Chemistry.

Regulation of mouse delta-opioid receptor gene transcription: involvement of the transcription factors AP-1 and AP-2.

J. Kraus, M. Wöltje, V. Höllt, 2002, Journal of neurochemistry.

The Role of Nuclear Factor κB in Tumor Necrosis Factor-Regulated Transcription of the Human μ-Opioid Receptor Gene

J. Kraus, V. Höllt, E. Giannini, 2003 .

The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene.

J. Kraus, V. Höllt, E. Giannini, 2003, Molecular pharmacology.

An Allelic Variation in the Human Prodynorphin Gene Promoter Alters Stimulus‐Induced Expression

E Rauch, A. Zimprich, J. Kraus, 2000, Journal of neurochemistry.

Regulation of mu-opioid receptors by cytokines.

J. Kraus, 2009, Frontiers in bioscience.

Transcriptional Regulation of the Human μ-Opioid Receptor Gene by Interleukin-6

J. Kraus, H. Ammer, V. Höllt, 2004, Molecular Pharmacology.

Epigenetic mechanisms involved in the induction of the mu opioid receptor gene in Jurkat T cells in response to interleukin-4.

J. Kraus, V. Höllt, Christine Börner, 2010, Molecular immunology.

Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants.

S. Grissmer, J. Kraus, M. Lang, 2009, Bioorganic & medicinal chemistry letters.

STAT6 transcription factor binding sites with mismatches within the canonical 5′‐TTC…GAA‐3′ motif involved in regulation of δ‐ and µ‐opioid receptors

J. Kraus, M. Wöltje, V. Höllt, 2004, Journal of Neurochemistry.

Rewarding effects of ethanol and cocaine in µ opioid receptor-deficient mice

H. Schroeder, H. Loh, A. Becker, 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

Accelerated kindling development in µ-opioid receptor deficient mice

H. Schroeder, A. Becker, J. Kraus, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Dopamine D1‐deficient mutant mice do not express the late phase of hippocampal long‐term potentiation

M. Krug, J. Kraus, H. Matthies, 1997, Neuroreport.

Identification of a cAMP-response element on the human proopiomelanocortin gene upstream promoter.

J. Kraus, V. Höllt, 1995, DNA and cell biology.

T-Cell Receptor/CD28-Mediated Activation of Human T Lymphocytes Induces Expression of Functional μ-Opioid Receptors

Burkhart Schraven, B. Schraven, J. Kraus, 2008, Molecular Pharmacology.

HARTREE FOCK CALCULATIONS ON THE EFFECTS OF LEWIS ACIDS ON THE HELIMERIZATION BARRIER OF A LACTONE-BRIDGED BIARYL

G. Bringmann, J. Kraus, U. Dauer, 1998 .

Interferon-gamma down-regulates transcription of the mu-opioid receptor gene in neuronal and immune cells.

U. Lendeckel, J. Kraus, V. Höllt, 2006, Journal of Neuroimmunology.

Expression and functions of μ‐opioid receptors and cannabinoid receptors type 1 in T lymphocytes

J. Kraus, 2012, Annals of the New York Academy of Sciences.

Regulation of Opioid and Cannabinoid Receptor Genes in Human Neuroblastoma and T Cells by the Epigenetic Modifiers Trichostatin A and 5-Aza-2’-Deoxycytidine

J. Kraus, E. Martella, V. Höllt, 2012, Neuroimmunomodulation.

Murrastifoline-F: first total synthesis, atropo-enantiomer resolution, and stereoanalysis of an axially chiral N,C-coupled biaryl alkaloid.

M. Wohlfarth, G. Bringmann, J. Kraus, 2001, Journal of the American Chemical Society.

Mechanisms of Opioid-Mediated Inhibition of Human T Cell Receptor Signaling1

B. Schraven, R. Hartig, M. Šmída, 2009, The Journal of Immunology.

Human T Cell Receptor Signaling Mechanisms of Opioid-Mediated Inhibition of Höllt and Jürgen

B. Schraven, R. Hartig, M. Šmída, 2009 .